Acute effects of atorvastatin on glomerular filtration rate, tubular function, blood pressure, and vasoactive hormones in patients with type 2 diabetes

Journal of Clinical Pharmacology

Volumn 50, Issue 7, 2010, Pages 816-822

  Paulsen, L ^a   Matthesen, S K ^a   Bech, J N ^a   Starklint, J ^a   Pedersen, E B ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Atorvastatin; Blood pressure; Diabetes type 2; Glomerular filtration rate; Sodium

Indexed keywords

ALBUMIN; ATORVASTATIN; CREATININE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TUBULE FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD PRESSURE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY TUBULES; MALE; MIDDLE AGED; PEPTIDE HORMONES; PYRROLES; SODIUM;

EID: 77953802869     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009350627     Document Type: Article

References (19)

1. Costa J., Borges M., David C., Vaz CA Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ. 2006 ; 332: 1115-1124.
2. Jandeleit-Dahm K., Cao Z., Cox AJ, Kelly DJ, Gilbert RE, Cooper ME Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl. 1999 ; 71: S31 - S36.
3. Usui H., Shikata K., Matsuda M., et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant. 2003 ; 18: 265-272.
4. Inman SR, Stowe NT, Cressman MD, et al. Lovastatin preserves renal function in experimental diabetes. Am J Med Sci. 1999 ; 317: 215-221.
5. Douglas K., Oĝ€™Malley PG, Jackson JL Meta-analysis: the effect of statins on albuminuria. Ann Intern Med. 2006 ; 145: 117-124.
6. Tonolo G., Melis MG, Formato M., et al. Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. Eur J Clin Invest. 2000 ; 30: 980-987.
7. Tonolo G., Velussi M., Brocco E., et al. Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes. Kidney Int. 2006 ; 70: 177-186.
8. Sorof J., Berne C., Siewert-Delle A., Jorgensen L., Sager P. Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients. Diabetes Res Clin Pract. 2006 ; 72: 81-87.
9. Paulsen L., Holm C., Bech JN, Starklint J., Pedersen EB Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. Nephrol Dial Transplant. 2008 ; 23: 1556-1561.
10. Pedersen EB, Eiskjaer H., Madsen B., Danielsen H., Egeblad M., Nielsen CB Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transplant. 1993 ; 8: 1064-1070.
11. Jensen KT, Carstens J., Ivarsen P., Pedersen EB A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma: reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest. 1997 ; 57: 529-540.
12. Pedersen RS, Bentzen H., Bech JN, Pedersen EB Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol. 2001 ; 280: F860 - F867.
13. Nesic Z., Todorovic Z., Stojanovic R., et al. Single-dose intravenous simvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in the rat. J Pharmacol Sci. 2006 ; 102: 413-417.
14. Jiang J., Roman RJ Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension. 1997 ; 30: 968-974.
15. Lam KS, Cheng IK, Janus ED, Pang RW Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia. 1995 ; 38: 604-609.
16. Asselbergs FW, Diercks GF, Hillege HL, et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004 ; 110: 2809-2816.
17. Wassmann S., Ribaudo N., Faul A., Laufs U., Bohm M., Nickenig G. Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dL. Am J Cardiol. 2004 ; 93: 84-88.
18. Welten Gmjm, Chonchol M., Schouten O., et al. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant. 2008 ; 23: 3867-3873.
19. Fu Q., Wang J., Boerma M., Berb©e M., Qiu X. Involvement of heat shock factor 1 in statin-induced Transcriptional upregulation of endothelial thrombomodulin. Circ Res. 2008 ; 103: 369-377.